Inhibition of the carnitine acylcarnitine carrier by carbon monoxide reveals a novel mechanism of action with non-metal-containing proteins

Free Radic Biol Med. 2022 Aug 1:188:395-403. doi: 10.1016/j.freeradbiomed.2022.06.244. Epub 2022 Jul 2.

Abstract

Both toxic and physiological effects of CO are mostly caused by well described interactions with heme-groups of proteins. Interactions of CO with non-heme proteins have also been unveiled. Besides interaction of CO with mitochondrial heme containing respiratory complexes, a BK channel and the phosphate carrier which do not contain metal cofactors, have been identified as CO targets. However, the molecular mechanisms of interaction with non-metal-containing proteins are not understood. We show in this work the effect of CO on the mitochondrial carnitine carrier (SLC25A20) using CORM-3, a widely recognized CO releasing compound. CO exerts an inhibitory effect at the micromolar concentration on the transport function of the transporter extracted from treated mitochondria. The effect is due to a single Cys residue, C136 as revealed by mass spectrometry analysis. A computational approach predicted the need for vicinal Asp and Lys residues for the C136 carbonylation to occur. These data demonstrate a novel mechanism of interaction of CO with a protein not containing metal atoms and will enable the prediction of CO targets.

Keywords: CORM-3; Carbon monoxide; Cysteine; Mitochondria; SLC25A20.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbon Monoxide* / metabolism
  • Carbon Monoxide* / pharmacology
  • Carnitine / analogs & derivatives
  • Carnitine / metabolism
  • Heme / metabolism
  • Membrane Transport Proteins / metabolism
  • Mitochondria / metabolism
  • Organometallic Compounds* / pharmacology

Substances

  • Membrane Transport Proteins
  • Organometallic Compounds
  • acylcarnitine
  • Heme
  • Carbon Monoxide
  • Carnitine